Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2005
12/27/2005US6979467 Microcapsules IV
12/27/2005US6979466 Iron oxide core with overcoating shell; antitumor agents
12/27/2005US6979464 Random copolymer of an N-alkyl- or N,N-dialkyl(meth)acrylamide and a hydrophilic comonomer; may be a graft polymer; drug delivery
12/27/2005US6979463 Stable extended release oral dosage composition
12/27/2005US6979462 Stabilization of solid drug formulations
12/27/2005US6979461 Method for producing liposome preparation
12/27/2005US6979460 lipid compounds with hydrophilic headgroups linked to the molecule through a vinyl ether linkage; use in liposome vesicle formation and the triggered release of the liposomal contents; drug delivery
12/27/2005US6979456 an emulsion of a taxane; storage-stable, non-aqueous, preconcentrate in a hydrophobic carrier and non-ionic surfactant; improved bioavailability, shelf life
12/27/2005US6979455 producing concentrate from a carrier having a modified ethylene polymer and optionally an olefin polymer, with one or more biocidal antimicrobial agents compounded therein; does not exhibit chalking and clumping of antimicrobial agent on surface
12/27/2005US6979454 Biologically active composition
12/27/2005US6979450 A transdermal drug delivery device, e.g. patches, comprising topical application of an antigen and physiologically effective solution; in particular, using mycobaterial antigens to detect tuberculosis; efficient; sensitivity
12/27/2005US6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/27/2005US6979442 granulocyte colony stimulating factor (G-CSF) and a stabilizing buffer; sustained release; for preventing or treating infections in mammals
12/27/2005US6979437 Drug delivering by inhaling or breathing to respiratory tract with a reduced drug dosage, comparing with traditional oral administration; dry powder drugs, emergency treatment
12/27/2005US6979326 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
12/27/2005US6979296 Methods for ultrasonic imaging and treating diseased tissues
12/27/2005US6978945 Dispensing device
12/27/2005CA2337509C Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
12/27/2005CA2327187C Transdermal therapeutic system containing pergolide
12/27/2005CA2280099C Medical aerosol formulations
12/27/2005CA2252050C Buccal, non-polar spray or capsule
12/27/2005CA2199249C Laminated tablet with pointed core
12/27/2005CA2166001C Stable solid formulation of enalapril salt and process for preparation thereof
12/27/2005CA2117257C Alginate-containing wound dressing
12/22/2005WO2005121348A1 Lipid encapsulated interfering rna
12/22/2005WO2005121215A2 Polypeptides with the capacity to entrap drugs and release them in a controlled way
12/22/2005WO2005121196A1 Novel temperature and ph sensitive copolymers
12/22/2005WO2005121171A1 Proteins stabilizing hydrophobic molecules
12/22/2005WO2005120605A2 Flow regulator
12/22/2005WO2005120590A1 Activatable particles, preparations and uses.
12/22/2005WO2005120585A1 Dual function polymer micelles
12/22/2005WO2005120579A1 Freeze-dried composition of inactivated virus envelope with membrane fusion activity
12/22/2005WO2005120578A2 Biodegradable drug-polymer delivery system
12/22/2005WO2005120574A1 Drug having regulatory cell ligand contained in liposome
12/22/2005WO2005120559A2 Charge gradient inhibition of trypanosoma cruzi and other parasite’s invasive action
12/22/2005WO2005120556A1 Human lysozyme medicine, its manufacturing method and application thereof
12/22/2005WO2005120555A1 Use of human lysozyme in preparation of medicine for treating acne
12/22/2005WO2005120551A1 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides
12/22/2005WO2005120548A1 Method of treating parkinson’s disease in humans by direct infusion of glial cell-line derived neurotrophic factor into the zona incerta
12/22/2005WO2005120527A1 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
12/22/2005WO2005120524A2 Nutritional formulations
12/22/2005WO2005120517A1 Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
12/22/2005WO2005120490A1 Capsule stable against mastication
12/22/2005WO2005120482A1 System and method for transdermal delivery of an anticoagulant
12/22/2005WO2005120481A1 Propafenone hydrochloride capsules containing microtablets
12/22/2005WO2005120473A2 Dermal peel-forming formulation
12/22/2005WO2005120472A1 Self-heating pharmaceutical patch
12/22/2005WO2005120471A1 Transdermal drug delivery device comprising extensor-relaxor means
12/22/2005WO2005120470A1 Matrix-controlled transdermal therapeutic system based on an adhesive for administering norelgestromin or the combination thereof with an estrogen
12/22/2005WO2005120469A1 Lipid nanoparticles as vehicles for nucleic acids, process for their preparation and use
12/22/2005WO2005120468A1 Multi-layered controlled-release methylphenidate pellet
12/22/2005WO2005120467A2 Dosage form containing the active ingredient cholylsarcosine
12/22/2005WO2005120466A2 Sugar coatings and methods therefor
12/22/2005WO2005120465A2 Multi-layer tablet comprising non-steroidal anti-inflammatory drugs decongestants and non-sedating antihistamines
12/22/2005WO2005120464A1 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
12/22/2005WO2005120463A1 Rapidly disintegrating tablets of risperidone
12/22/2005WO2005120462A2 Biodegradable and biocompatible crosslinked polymer hydrogel prepared from pva and/or peg macromer mixtures
12/22/2005WO2005120461A2 Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
12/22/2005WO2005120460A1 Sterol enriched mixed lammelarity amphotericin intercalating liposomes in saline and the process for their preparation
12/22/2005WO2005120459A2 Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
12/22/2005WO2005120458A1 Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use
12/22/2005WO2005120457A1 Immune enhancing compositions and methods of use thereof
12/22/2005WO2005120456A2 Formulation of eletriptan
12/22/2005WO2005120455A1 Soluble strip for oral or topical administration
12/22/2005WO2005120454A2 Composite material for use as protein carrier
12/22/2005WO2005120453A1 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons
12/22/2005WO2005120435A2 Method for preparing sustained release compositions and the use of said compositions for treating chronic diseases of central nervous system (cns)
12/22/2005WO2005120413A1 An absorbent article containing fragrance
12/22/2005WO2005120412A1 An absorbent article containing fragrance
12/22/2005WO2005120408A1 Improvements in and relating to pressure garments
12/22/2005WO2005120173A2 Anti-microbial activity of biologically stabilized silver nano particles
12/22/2005WO2005120152A2 Cationic lipids and methods of use
12/22/2005WO2005091852A3 Multilayered transdermal drug delivery device
12/22/2005WO2005090461A3 Thermoplastic films and methods for making
12/22/2005WO2005089779A3 Rapidly disintegrating taste-masked tablet
12/22/2005WO2005060945A3 Intranasal compositions comprising zolpidem
12/22/2005WO2005051176A3 Hemostatic pressure plug
12/22/2005WO2005046634A8 Gastric juice-resistant form of administration
12/22/2005WO2005046569A3 Pharmaceutical compositions for the treatment of sars
12/22/2005WO2005030177A3 Pharmaceutical formulation with improved stability
12/22/2005WO2005025647A3 Medication delivery device
12/22/2005WO2005023233A3 Antimicrobial compositions and methods
12/22/2005WO2004060059A3 Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes
12/22/2005US20050283098 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
12/22/2005US20050283045 Capsule medical instrument with oxygen generator
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282885 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/22/2005US20050282869 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
12/22/2005US20050282836 Solid orally ingestible formulations of tetrodotoxin
12/22/2005US20050282784 Therapy using a combination of raloxifene and alendronate
12/22/2005US20050282783 Obtained by reacting sodium zoledronate with calcium orthophosphates in water, bone remodeling equilibrium; the local treatment of a bone problem on the main at-risk sites identified (neck of the femur )
12/22/2005US20050282776 Injectable pharmaceutical compositions comprising sodium diclofenac and beta-cyclodextrin
12/22/2005US20050282774 Method and pharmaceutical to treat spinal discs
12/22/2005US20050282759 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
12/22/2005US20050282756 Oral delivery of peptide pharmaceutical compositions
12/22/2005US20050282752 IL-1ra variants
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/22/2005US20050282731 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282012 Method of growing crystals
1 ... 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 ... 2991